KIORA PHARMACEUTICALS INC (KPRX): auditor change — Kiora Pharmaceuticals dismisses EisnerAmper, appoints Haskell & White as auditor

KIORA PHARMACEUTICALS INC

Dismissed EisnerAmper effective March 24, 2023 after competitive bid process.
No disagreements with EisnerAmper; material weakness in internal controls noted.
Prior audit report included going concern explanatory paragraph.
Appointed Haskell & White LLP as independent auditor for fiscal year 2023.
No prior consultations with Haskell & White on accounting matters.

item 4.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

KIORA PHARMACEUTICALS INC engaged Haskell & White LLP as its auditor.

Action: engagement
Auditor: Haskell & White LLP

Exact text from the filing

the Audit Committee has appointed Haskell & White LLP as the Company’s independent registered public accounting firm, effective March 24, 2023

View on SEC.gov

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

KIORA PHARMACEUTICALS INC dismissed EisnerAmper LLP as its auditor.

Action: dismissal
Auditor: EisnerAmper LLP
Successor: Haskell & White LLP

Exact text from the filing

the Audit Committee dismissed EisnerAmper as the Company’s independent registered public accounting firm as of the Effective Date

View on SEC.gov

Browse all auditor changes →

KIORA PHARMACEUTICALS INC filing history →

Source: SEC EDGAR

accession 0001372514-23-000053

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.